Skip to main content
NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%NVDA+0.72%AAPL-0.44%MSFT-0.85%GOOGL-1.06%AMZN+0.39%TSM+1.40%SPCX-0.40%META-0.23%AVGO+2.33%TSLA+1.03%LLY+0.45%BRK-B+1.17%MU+2.34%SKHY+4.09%WMT+0.33%JPM+0.74%AMD+2.80%XOM+0.73%V-0.92%JNJ+0.94%ASMLa+1.29%MA-1.62%ABBV+0.40%INTC+4.04%CVX-0.51%1398.HK+2.15%0700.HK-0.31%COST+0.18%CSCO+3.51%KO-0.01%ORCL-0.08%PG-0.68%UNH-1.77%1816.HK+1.32%BAC-0.08%3988.HK+0.66%HD-0.14%CAT+0.75%0857.HK-0.98%PM+1.20%0939.HK+0.81%AP2d+1.11%AMAT+2.74%1288.HK+0.60%GE+0.98%LRCX+3.22%DELL+2.37%0005.HK-5.56%HSBA.L-6.80%NVS+1.78%NZDMXN+0.60%USDJPY+0.58%NZDJPY+0.58%EURNZD-0.53%AUDJPY+0.52%EURUSD-0.52%AUDDKK+0.47%NZDCHF+0.47%USDCHF+0.46%CADJPY+0.46%EURAUD-0.45%GBPTRY+0.41%AUDCHF+0.41%GBPUSD-0.41%GBPNZD-0.40%EURCAD-0.37%NZDSGD+0.36%GBPAUD-0.35%EURSEK-0.34%CADCHF+0.33%GBPHKD+0.32%USDPLN+0.31%EURCNH-0.30%GBPCAD-0.29%GBPMXN-0.28%EURHKD-0.28%USDDKK+0.27%USDMXN+0.27%EURNOK-0.24%EURSGD-0.24%AUDSGD+0.23%AUDNOK+0.22%CHFSEK-0.21%USDTRY+0.18%USDILS+0.16%GBPJPY+0.16%NOKJPY+0.15%GBPSGD-0.15%USDZAR+0.14%SGDJPY+0.14%PLNJPY-0.14%USDCAD+0.13%EURZAR-0.13%CHFJPY+0.13%NZDCAD+0.12%CHFNOK-0.11%EURGBP-0.10%CHFSGD-0.10%USDSEK-0.07%AUDNZD-0.07%EURJPY+0.07%EURCHF-0.07%AUDUSD-0.06%AUDCAD+0.06%USDTHB-0.06%EURPLN+0.04%GBPZAR-0.04%GBPCHF+0.04%USDCOP-0.04%USDHKD+0.04%USDSGD+0.03%USDNOK+0.03%USDCNH-0.02%EURCZK0.00%EURDKK0.00%NZDUSD0.00%COFFEE-1.76%XPTUSD-1.59%GAGUSD-1.23%XAGUSD-1.23%HG1+1.17%SUGAR+0.92%XNGUSD+0.75%S1+0.48%UKOIL-0.41%COCOA+0.31%USOIL-0.25%W1+0.25%BTCUSD-0.14%ETHUSD+23.96%USDTUSD0.00%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+1.60%DOGEUSD+20.65%XMRUSDT-0.52%LINKUSD+25.58%BCHUSDT+0.05%XLMUSD-0.69%UNIUSD-1.61%LTCUSD+17.89%SUIUSD-0.56%HBARUSDT-1.92%TONUSD+41.71%TAOUSDT-1.22%AAVEUSD-3.15%DOTUSDT-2.38%ICPUSDT-2.13%ONDOUSDT-1.78%WLDUSDT-0.78%ARBUSDT-1.00%JUPUSDT-1.50%INJUSDT-2.90%ATOMUSDT-1.80%STXUSDT-1.73%TIAUSDT-3.99%PYTHUSDT-3.58%FETUSDT-0.37%SEIUSDT-1.38%IMXUSDT-1.38%GRTUSDT-2.00%OPUSDT-1.09%IOTAUSDT+0.31%WIFUSDT-1.72%POLUSDT-1.83%AXSUSDT-0.90%EOSUSDT+0.58%FARTCOINUSDT+0.44%DYDXUSDT-0.42%GALAUSDT-1.91%ORDIUSDT-0.38%RONINUSDT+0.02%NOTUSDT-0.80%
GR

GRAIL Inc. (GRAL)

NASDAQ • Healthcare

$139.91
+$7.35 (+5.6%)
Market closed

Last close at October 26, 2026 at 20:00 UTC

Open$134.83
Day Range$132.75 - $141.68
Avg. Volume (3M)987.8K
Market Cap$6.2B
52 Week Range
$41.5$166.48
Next EarningsIn 8 daysNov 4, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$165.2M
Net Income (TTM)
-$391.5M
EPS (TTM)
-$9.75
ROA (TTM)
-13.77%
Current Ratio
10.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+26.7%Q1 2026-$2.44
+17.1%Q2 2026-$2.29
+3.8%Q3 2026-$2.56
Next

Nov 4

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.8%

GRAIL topped consensus on both the top and bottom line in the second fiscal quarter of 2026, reported August 5, 2026, as revenue of $44.7 million exceeded the $42.4 million estimate (+5.4%) and EPS of -$2.56 topped the -$2.66 estimate by $0.10. Revenue rose ~26% year over year to about $44.7 million (up from $35.5 million a year ago), reflecting the company’s blood-based cancer detection business led by its Galleri multi-cancer early detection test and related diagnostic support and research services. Net income was a loss of roughly $110.2 million, improving ~3% from a loss of $114.0 million a year ago, while operating income was an operating loss of about $173.8 million. On a per-share basis, EPS improved ~20% year over year from -$3.18 to -$2.56. For the next period, consensus calls for EPS of -$2.50 on revenue of $44.2 million.

Next report — what to expect

GRAIL Inc. (GRAL) reports on November 11, 2026. The next-period consensus calls for EPS of -$2.501 on revenue of $44.2 million. For trailing context, revenue grew +25.7% year over year last quarter. GRAIL has beaten EPS in 7 of 8 most recent quarters, making any change in profitability trends a key watch.

View full earnings history

About GRAIL Inc.

GRAIL Inc. (NASDAQ: GRAL) develops blood-based cancer detection and related services in the healthcare diagnostics and research business. In FY2025, the company generated $147.2 million in revenue. Its core offerings span population screening, diagnostic support, and research services tied to precision oncology.

Name
GRAIL Inc.
CEO
Joshua J. Ofman
Website
www.grail.com
Industry
Healthcare
Year Founded
2015
Employees
910

Today's Snapshot

AI-generated

GRAL closed 5.5% higher at 139.91, while its sector was flat. Earnings are due from GRAL on 4 November.

Trading Volume

Above 10d avg 754.2K

858.9K

vs S&P 500 Today

Strong Outperformance

+4.86%

Updated: October 26, 2026 at 20:11 UTC

GRAL Headlines

FDA panel to review Grail’s Galleri test

September 23, 2026

3 min read
View All News

Technical Indicators

5 Buy3 Neutral0 Sell
GRAL is showing a technically constructive picture as price sits well above its short-, medium- and long-term moving averages while the ADX signals a strong trend. Momentum readings are positive and RSI is in neutral-to-bullish territory, which supports the overall buy stance, while MACD is mildly supportive. Volatility is elevated with an ATR near ten dollars (about 7%), so intraday swings can be wide, and the classic pivot around 131 acts as nearby support. Volume-based OBV also supports accumulation despite the wide trading range. Technical takeaway: Strong Buy — trend and momentum favor buyers, but expect elevated volatility.
All signals
  • EMA (5 indicators)$87.62 - $131.95
    Buy
  • RSI (14)60.51
    Neutral
  • Stochastic %K (14, 3, 3)45.28
    Neutral
  • MACD Level (12, 26)6.81
    Neutral

Peers & Related Assets

NTRANatera, Inc.
$404.9+0.2%
GHGuardant Health, Inc.
$173.25+2.5%
NEONeoGenomics, Inc.
$16.69+0.6%
WGSGeneDx Holdings Corp.
$61.26+9.1%
CSTLCastle Biosciences, Inc.
$33.3+0.7%
MYGNMyriad Genetics, Inc.
$6.02+3.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.